AI assistant
Sending…
Moberg Pharma — Major Shareholding Notification 2014
May 30, 2014
3174_iss_2014-05-30_bb2ba387-7f7c-4514-9e50-30c09ed38f42.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Moberg Pharma AB (publ)
Holder
Östersjöstiftelsen
Instrument
| Instrument | Common shares SE0003613090 | |
|---|---|---|
| Before the transaction | ||
| Shares | 2,274,179 | |
| Voting rights | 2,274,179 | |
| Transaction | ||
| Reason for major shareholding notification Share loan | ||
| Date | 30/05/2014 | |
| Limit for number of shares | 5 % | |
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 205,214 | |
| Directly held voting rights | 205,214 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 1.73 % | |
| Directly held voting rights | 1.73 % | |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | ||
| Instruments - FITA Ch. 4, section 2, first | ||
| paragraph, line 2 | ||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total |
Published
30/05/2014 16:11
Contact
Name Mattias Klintemar
Phone 08-6085156 Email [email protected]
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Moberg Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 13